IP Verse

Biomarin Pharmaceutical patent opposition analysis

Get complete Patent Opposition Report for Biomarin Pharmaceutical

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest patents of Biomarin Pharmaceutical opposed by its competitors

Explore Biomarin Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3328416Mar 13, 2024Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal Dysplasia3
EP3461503May 11, 2022Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring5
EP3138566Jan 26, 2022Treatment Of Phenylketonuria With Bh43
EP3175863Dec 1, 2021Variants Of C-Type Natriuretic Peptide1
EP2545939Dec 16, 2020Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring5

Top competitors of Biomarin Pharmaceutical